4HF Biotec
4HF Biotec is a biopharmaceutical company founded in 2015, dedicated to developing innovative anti-cancer therapies with enhanced precision targeting tumor cells and minimal side effects. Their core offering is the 4HF CancerDataMiner™ platform, which integrates cancer data, computational sciences, and AI-driven drug discovery. The company focuses on Small Molecule Drug Conjugates (SMDCs) to improve the delivery of chemotherapeutics. 4HF Biotec offers in silico research services, including MoA Finder, Biomarker Discovery, and Target Investigation, to support pharmaceutical and biotech industries. They have a cross-functional team of experts in oncology, drug development, and data science and actively seek collaborations. Seed funding was provided by Professor H.H. Fiebig, with additional funding from Invest BW.
4HF Biotec
4HF Biotec is a biopharmaceutical company founded in 2015, dedicated to developing innovative anti-cancer therapies with enhanced precision targeting tumor cells and minimal side effects. Their core offering is the 4HF CancerDataMiner™ platform, which integrates cancer data, computational sciences, and AI-driven drug discovery. The company focuses on Small Molecule Drug Conjugates (SMDCs) to improve the delivery of chemotherapeutics. 4HF Biotec offers in silico research services, including MoA Finder, Biomarker Discovery, and Target Investigation, to support pharmaceutical and biotech industries. They have a cross-functional team of experts in oncology, drug development, and data science and actively seek collaborations. Seed funding was provided by Professor H.H. Fiebig, with additional funding from Invest BW.